Inactive Instrument

Rite Aid Corporation Stock price Nyse

Equities

US7677541044

Drug Retailers

Sales 2022 24.57B Sales 2023 24.09B Capitalization 196M
Net income 2022 -538M Net income 2023 -750M EV / Sales 2022 0.26 x
Net Debt 2022 5.89B Net Debt 2023 5.65B EV / Sales 2023 0.24 x
P/E ratio 2022
-0.92 x
P/E ratio 2023
-0.26 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 97.31%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 55 23-10-14
Director of Finance/CFO 53 99-12-31
Director/Board Member 62 19-04-09
Members of the board TitleAgeSince
Director/Board Member 73 18-10-29
Director/Board Member 68 18-10-29
Chairman 72 13-05-19
More insiders
Rite Aid Corporation is a full-service pharmacy engaged in improving health outcomes. The Company meets customer needs with a range of solutions that offer convenience, including retail and delivery pharmacy, as well as services offered through its wholly owned subsidiaries Health Dialog Services Corporation (Health Dialog) and Bartell Drug Company (Bartell Drugs). Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs supports the health and wellness needs in the Seattle area. Its Retail Pharmacy segment’s primary business is the sale of prescription drugs and related consultation to its customers. Additionally, the Retail Pharmacy segment sells a full selection of health and beauty aids and personal care products, seasonal merchandise, and a large private brand product line. The Company operates more than 1,700 retail pharmacy locations across 16 states.
More about the company
  1. Stock
  2. Equities
  3. Stock Rite Aid Corporation
  4. Stock Rite Aid Corporation - Nyse